Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
Avi Kenny(University of Washington), M. Juliana McElrath(Fred Hutch Cancer Center), Derrick Goodman(Duke Medical Center), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Janine van Duijn(Janssen (Netherlands)), One Dintwe(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Glenda Gray(South African Medical Research Council), Taylor Keyes(Duke University), Hanneke Schuitemaker(Johnson & Johnson (Israel)), David Benkeser(Emory University), Jenny Hendriks(Janssen (Netherlands)), Alex Luedtke(University of Washington), Bette Korber(Los Alamos National Laboratory), Ludo Lavreys(Janssen (Belgium)), Susan Buchbinder(University of California, San Francisco), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Erica N. Borducchi(Beth Israel Deaconess Medical Center), Craig A. Magaret(Fred Hutch Cancer Center), Leigh H. Fisher(Fred Hutch Cancer Center), Edith Swann(National Institutes of Health), Faatima Laher Omar, Lars van der Laan(University of Washington), Susan Zolla‐Pazner(Icahn School of Medicine at Mount Sinai), Laura Pattacini(Janssen (Netherlands)), Guido Ferrari(Duke University), Sherry Stanfield-Oakley(Duke University), Randy I. Burnham(Fred Hutch Cancer Center), Dan H. Barouch(Beth Israel Deaconess Medical Center), Dieter Mielke(Duke University), Lawrence Corey(Fred Hutch Cancer Center), Brooke Dunn(Duke University), Youyi Fong(Fred Hutch Cancer Center), Jack Heptinstall(Duke University), Maria Grazia Pau, Kathryn Mngadi(Aurum Institute), Sharon Khuzwayo, Huub C. Gelderblom, Lindsay N. Carpp(Fred Hutch Cancer Center), Steven Nijs(Janssen (Netherlands)), Elena E. Giorgi(Fred Hutch Cancer Center), Ollivier Hyrien(Fred Hutch Cancer Center), Lu Zhang(Qingdao University of Science and Technology), Tom van de Kerkhof(Janssen (Netherlands)), Rodger Zou(Fred Hutch Cancer Center), Wouter Willems(Janssen (Belgium)), Stephen C. De Rosa(University of Washington), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheetal Sawant(Duke University), Frank Tomaka(Janssen (United States)), Kelly E. Seaton(International Vaccine Institute)
Cited by 17
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k